Skip to content
Sign in

MD · NYSE

Pediatrix Medical Group (MD) Stock Price & Fundamentals

$850.30−0.54%−$4.62End-of-day price as of Oct 9, 2026

Pediatrix Medical Group (MD) closed at $850.30 on Oct 9, 2026, down 0.54% from the previous close of $854.92.

Share price, past year

1Y +6.48%

52-week range $690.68 – $854.92. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$850.30
Sep 30, 2026$836.46
Aug 31, 2026$768.05
Jul 31, 2026$714.33
Jun 30, 2026$703.81
May 29, 2026$743.11
Apr 30, 2026$769.89
Mar 31, 2026$776.05
Feb 27, 2026$797.19
Jan 30, 2026$800.10
Dec 31, 2025$802.30
Nov 28, 2025$824.24
Oct 31, 2025$800.82

Key statistics

Market cap
$69.06B
P/E (TTM)
406.8
EPS (TTM)
$2.09
Revenue (TTM)
$1.95B
Net income (TTM)
$174.81M
Shares outstanding
81.2M
Dividend yield
—
52-week range
$690.68 – $854.92

Pediatrix Medical Group's market cap is $69.06B, based on a share price of $850.30 and 81.2M shares outstanding as of Jun 30, 2026.

Financials

Pediatrix Medical Group reported revenue of $1.91B for fiscal 2025, down 4.92% from fiscal 2024.

Pediatrix Medical Group earned net income of $165.39M in fiscal 2025, a net margin of 8.6%.

Annual revenue

FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
Pediatrix Medical Group annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Dec 31, 2025$1.91B−4.9%$165.39M8.6%$1.94—
FY2024ended Dec 31, 2024$2.01B+0.9%−$99.07M−4.9%−$1.19—
FY2023ended Dec 31, 2023$1.99B+1.2%−$60.41M−3.0%−$0.73—
FY2022ended Dec 31, 2022$1.97B+3.2%$66.34M3.4%$0.79—
FY2021ended Dec 31, 2021$1.91B+10.2%$130.96M6.9%$1.53—
FY2020ended Dec 31, 2020$1.73B−2.6%−$796.49M−45.9%−$9.55—
FY2019ended Dec 31, 2019$1.78B+3.3%−$1.50B−84.2%−$17.83—
FY2018ended Dec 31, 2018$1.72B−47.0%$268.63M15.6%$2.93—
FY2017ended Dec 31, 2017$3.25B+2.2%$320.37M9.9%$3.45—
FY2016ended Dec 31, 2016$3.18B—$324.91M10.2%$3.49—
Pediatrix Medical Group quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q2 FY2026ended Jun 30, 2026$487.78M$39.84M$0.49
Q1 FY2026ended Mar 31, 2026$476.20M$29.57M$0.36
Q4 FY2025ended Dec 31, 2025$493.77M$33.68M$0.40
Q3 FY2025ended Sep 30, 2025$492.88M$71.71M$0.84
Q2 FY2025ended Jun 30, 2025$468.84M$39.26M$0.46
Q1 FY2025ended Mar 31, 2025$458.36M$20.74M$0.24
Q4 FY2024ended Dec 31, 2024$502.36M$30.48M$0.37
Q3 FY2024ended Sep 30, 2024$511.16M$19.44M$0.23

Company profile

Name
Pediatrix Medical Group, Inc.
Ticker
MD
Exchange
NYSE
Industry (SEC SIC)
Services-Hospitals
Headquarters
1301 Concord Terrace, Sunrise, FL 33323
Incorporated in
FL
Fiscal year ends
December
SEC CIK
0000893949

Recent SEC filings

Frequently asked questions

What is Pediatrix Medical Group's stock price?

Pediatrix Medical Group (MD) closed at $850.30 on Oct 9, 2026, down 0.54% from the previous close of $854.92.

What is Pediatrix Medical Group's market cap?

Pediatrix Medical Group's market cap is $69.06B, based on a share price of $850.30 and 81.2M shares outstanding as of Jun 30, 2026.

How much revenue does Pediatrix Medical Group make?

Pediatrix Medical Group reported revenue of $1.91B for fiscal 2025, down 4.92% from fiscal 2024.

What is MD's P/E ratio?

Pediatrix Medical Group's price-to-earnings ratio is 406.8, based on trailing twelve-month diluted EPS of $2.09.

Does Pediatrix Medical Group pay a dividend?

Pediatrix Medical Group's recent filings report no dividends declared over the last four quarters.

Sources and methodology

Fundamentals come from Pediatrix Medical Group, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures